Parkinson's Disease Trial, Recruiting NCT06960096 Sponsor: Medical University of South Carolina Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT06960096
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have been diagnosed with Parkinson's disease according to a specific set of recognised diagnostic guidelines (called the UK Brain Bank criteria), have had a full neurological and neuropsychological assessment at MUSC's movement disorder centre, and have been selected to receive a brain stimulation device (called deep brain stimulation, or DBS) implanted on one or both sides of the brain

Who may not be able to join:

  • People who have vision or hearing problems that have not been corrected, based on what they report themselves
  • People who are pregnant or planning to become pregnant during the study
  • People who have a history of a neurological condition other than Parkinson's disease, including previous stroke, significant head injury, epilepsy, or seizures
  • People who experience claustrophobia (fear of enclosed spaces) or who are unable to lie flat and still inside an MRI scanner
  • People who have a lung condition called COPD that requires them to use supplemental oxygen
  • People who have metal implants in their body that are not safe to use with MRI scanning, such as surgical clips, staples, or heart pacemakers

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Daniel Lench, PhD, Medical University of South Carolina

Phone: 843-792-0235

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
21 August 2025
Est. completion
1 April 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in executive function performance

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov